Coxibs: Pharmacology, Toxicity and Efficacy in Cancer Clinical Trials
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-642-30331-9_4.pdf
Reference149 articles.
1. Andersohn F, Suissa S, Garbe E (2006) Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 113:1950–1957
2. Antman EM, Bennett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American heart association. Circulation 115:1634–1642
3. Anzellotti P, Capone ML, Jeyam A et al (2011) Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. Arthritis Rheum 63:850–859
4. Arber N (2008) Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point. Cancer Epidemiol Biomarkers Prev 17:1852–1857
5. Arber N, Eagle CJ, Spicak J et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355:885–895
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Parecoxib decreases cellular growth and Bcl‐2 protein levels in primary cultures of keloid fibroblasts;International Wound Journal;2024-03
2. Ruthenium–dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation;Cancer Chemotherapy and Pharmacology;2024-01-09
3. Comparative pharmacoepidemiological analysis on analgesics consumption in the Republic of Serbia and Nordic countries in the period 2015-2018;Acta Facultatis Medicae Naissensis;2024
4. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair;Purinergic Signalling;2023-04-13
5. GINSENG BERRY CONCENTRATE PREVENTS COLON CANCER VIA CELL CYCLE, APOPTOSIS REGULATION, AND INFLAMMATION-LINKED TH17 CELL DIFFERENTIATION;J PHYSIOL PHARMACOL;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3